MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$265K
Net Income
-$2,932K
Net Profit Margin
-1106.42%
EPS
-$0.03
Unit: Thousand (K) dollars
Revenue Breakdown
White Labeling Services
Wellness And Lifestyle
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
265
317
91*
191
Cost of revenue
217
262
173*
92
Selling, general, and administrative expenses
1,442
1,241
194*
1,410
Research and development expenses
1,390
1,272
263*
1,588
Operating loss
-2,784
-2,458
-539*
-2,899
Other (expense)/income, net
-152
56
1,523*
1,078
Gain before income taxes
-2,936
-2,402
984*
-1,821
Income tax expense
0
0
0*
0
Net gain attributable to common stockholders
-2,936
-2,402
984*
-1,821
Foreign currency translation adjustments
4
-8
-7*
-19
Comprehensive gain
-2,932
-2,410
977
-1,840
Basic EPS
-0.03
-0.02
0.01
-0.02
Diluted EPS
-0.03
-0.02
0.01
-0.02
Basic Average Shares
100,331,320
98,161,733
93,069,641
90,457,910
Diluted Average Shares
100,331,320
98,161,733
93,069,641
90,457,910
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive gain
-$2,932K
(-83.02%↓ Y/Y)
Foreign currency
translation adjustments
$4K
(233.33%↑ Y/Y)
Net gain
attributable to common...
-$2,936K
(-83.61%↓ Y/Y)
Gain before income
taxes
-$2,936K
(-83.61%↓ Y/Y)
White Labeling
Services
$256K
(-20.50%↓ Y/Y)
Wellness And Lifestyle
$9K
(50.00%↑ Y/Y)
Operating loss
-$2,784K
(-46.14%↓ Y/Y)
Other
(expense)/income, net
-$152K
(-149.67%↓ Y/Y)
Revenue
$265K
(-19.21%↓ Y/Y)
Selling, general, and
administrative expenses
$1,442K
(19.37%↑ Y/Y)
Research and development
expenses
$1,390K
(63.34%↑ Y/Y)
Cost of revenue
$217K
(24.71%↑ Y/Y)
Buy us a coffee
IGC Pharma, Inc. (IGC)
IGC Pharma, Inc. (IGC)